How many institutional investors hold CHRS?

2 tracked institutional investors disclosed a position in CHRS (COHERUS ONCOLOGY INC) in their most recent 13F filing.

Who is the largest institutional holder of CHRS?

Izzy Englander, Millennium Management, holds the largest disclosed position in CHRS, valued at $937,840.

Where does this CHRS ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CHRS — COHERUS ONCOLOGY INC

Name: COHERUS ONCOLOGY INC (CHRS) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About COHERUS ONCOLOGY INC (CHRS)

COHERUS ONCOLOGY INC (CHRS) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $937,840. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CHRS

100

/100

Strong Institutional Accumulation

Added / Increased1

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track CHRS

/100

Undiscovered

2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded

151015+

CHRS Ownership Composition

How COHERUS ONCOLOGY INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

100% of tracked value

Institutions

tracked investors

Total Reported

$1.2M

combined 13F value

Other100.0%

Other(2)

100.0%

Tracked investors reporting CHRS

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	312K	$527.3K	0.00%	Mar 31, 2026
Ken Griffin	Citadel Advisors	393K	$664.2K	0.00%	Mar 31, 2026

Izzy EnglanderMar 31, 2026
Millennium Management
Shares
312K
Value
$527.3K
% Portfolio
0.00%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
393K
Value
$664.2K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$937.8K	Feb 17, 2026

Izzy Englander
New
$937.8KFeb 17, 2026

Frequently asked questions

How many institutional investors hold CHRS?: 2 tracked institutional investors disclosed a position in CHRS (COHERUS ONCOLOGY INC) in their most recent 13F filing.
Who is the largest institutional holder of CHRS?: Izzy Englander, Millennium Management, holds the largest disclosed position in CHRS, valued at $937,840.
Did institutional ownership of CHRS increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited CHRS.
Where does this CHRS ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.